Airway vascular endothelial function in healthy smokers without systemic endothelial dysfunction

Chest

Volumn 143, Issue 6, 2013, Pages 1733-1739

  Mendes, Eliana S ^a   Cancado, Jose Eduardo D ^a   Rebolledo, Patricia ^a   Arana, Joahna ^a   Parker, Meela ^a   Gonzalez, Alex ^a   Hurwitz, Barry E ^a   Wanner, Adam ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FLUTICASONE PROPIONATE; GLUCOCORTICOID; INTERLEUKIN 6; PLACEBO; SALBUTAMOL;

ADULT; AIRWAY BLOOD FLOW; AIRWAY VASCULAR ENDOTHELIAL FUNCTION; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOW; BRACHIAL ARTERY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED VASODILATION; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LUNG CIRCULATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SMOKING; VASCULAR ENDOTHELIUM; VASODILATATION; VENOUS BLOOD;

EID: 84878547144     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1033     Document Type: Article

References (40)

1. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-dependent and potentially reversible impairment of endothelium-dependent dilatation in healthy young adults. Circulation. 1993;88(5 pt 1):2149-2155.
2. Butler R, Morris AD, Struthers AD. Cigarette smoking in men and vascular responsiveness. Br J Clin Pharmacol. 2001;52(2):145-149.
3. Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endotheliumdependent vasodilatation. Circulation. 2001;104(16):1905- 1910.
4. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731-1737.
5. Adams MR, Robinson J, McCredie R, et al. Smooth muscle dysfunction occurs independently of impaired endotheliumdependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 1998;32(1):123-127.
6. Wiesmann F, Petersen SE, Leeson PM, et al. Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2004;44(10):2056-2064.
7. Hayward CS, Kraidly M, Webb CM, Collins P. Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol. 2002;40(3):521-528.
8. Lind L, Sarabi M, Millgård J. Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin Physiol. 1998;18(2):81-87.
9. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Covic M. Haemodialysis acutely improves endothelium-independent vaso motor function without significantly influencing the endotheliummediated abnormal response to a beta 2-agonist. Nephrol Dial Transplant. 2004;19(3):637-643.
10. Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol. 2002;39(2):251-256.
11. Münzel T, Gori T, Bruno RM, Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J. 2010;31(22):2741- 2748.
12. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 1995;92(5):1094-1100.
13. Campisi R, Czernin J, Schöder H, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation. 1998;98(2):119-125.
14. Heffernan KS, Karas RH, Patvardhan EA, Kuvin JT. Endothelium-dependent vasodilation is associated with exercise capacity in smokers and non-smokers. Vasc Med. 2010;15(2):119-125.
15. Mendes ES, Campos MA, Wanner A. Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. Chest. 2006;129(4):893-898.
16. Mendes ES, Horvath G, Monzon ME. Casalina-Matsuda SM, Wanner A. Endothelial function in healthy smokers. J Appl Physiol. 2008;105(1):54-57.
17. Schindler C, Dobrev D, Grossmann M, Francke K, Pittrow D, Kirch W. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans. Clin Pharmacol Ther. 2004;75(1):49-59.
18. Carvalho P, Johnson SR, Charan NB. Non-cAMP-mediated bronchial arterial vasodilation in response to inhaled b-agonists. J Appl Physiol. 1998;84(1):215-221.
19. Wanner A, Mendes ES, Atkins ND. A simplified noninvasive method to measure airway blood flow in humans. J Appl Physiol. 2006;100(5):1674-1678.
20. Scuri M, McCaskill V, Chediak AD, Abraham WM, Wanner A. Measurement of airway mucosal blood flow with dimethylether: validation with microspheres. J Appl Physiol. 1995;79(4):1386-1390.
21. Bjarnegård N, Ahlgren AR, Sandgren T, Sonesson B, Länne T. Age affects proximal brachial artery stiffness; differential behavior within the length of the brachial artery? Ultrasound Med Biol. 2003;29(8):1115-1121.
22. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations . Am Rev Respir Dis. 1981;123(6):659-664.
23. Fratta Pasini A, Albiero A, Stranieri C, et al. Serum oxidative stress-induced repression of Nrf2 and GSH depletion: a mechanism potentially involved in endothelial dysfunction of young smokers. PLoS ONE. 2012;7(1): e30291.
24. Ludwig A, Jochmann N, Kertesz A, et al. Smoking decreases the level of circulating CD34+ progenitor cells in young healthy women - a pilot study. BMC Womens Health. 2010;10:20.
25. Yufu K, Takahashi N, Okada N, et al. Influence of systolic blood pressure and cigarette smoking on endothelial function in young healthy people. Circ J. 2009;73(1):174-178.
26. Sin DD, Man SFP, Marciniuk DD, et al ABC (Advair, Biomarkers in COPD) Investigators. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(11):1207-1214.
27. Brieva JL, Danta I, Wanner A. Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma. Am J Respir Crit Care Med. 2000;161(1):293-296.
28. Valen G, Kawakami T, Tähepôld P, et al. Pretreatment with methylprednisolone protects the isolated rat heart against ischaemic and oxidative damage. Free Radic Res. 2000;33(1):31-43.
29. van Beurden WJC, Harff GA, Dekhuijzen PN, van der Poel-Smet SM, Smeenk FWJM. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration. 2003;70(3):242-248.
30. Ferreira IM, Hazari MI, Gutierrez Z, Zamel N, Chapman K. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of beclomethasone. Am J Respir Crit Care Med. 2001;164(6):1012-1015.
31. Bobadilla NA, Tapia E, Jiménez F, et al. Dexamethasone increases eNOS gene expression and prevents renal vasoconstriction induced by cyclosporin. Am J Physiol. 1999;277(3 pt 2): F464-F471.
32. Aida K, Shi Q, Wang J, et al. The effects of betamethasone (BM) on endothelial nitric oxide synthase (eNOS) expression in adult baboon femoral arterial endothelial cells. J Steroid Biochem Mol Biol. 2004;91(4-5):219-224.
33. Pinnock SB, Balendra R, Chan M, Hunt LT, Turner-Stokes T, Herbert J. Interactions between nitric oxide and corticosterone in the regulation of progenitor cell proliferation in the dentate gyrus of the adult rat. Neuropsychopharmacology. 2007;32(2):493-504.
34. Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol. 1995;268(1 pt 1): L41-L46.
35. Limbourg FP, Huang Z, Plumier JC, et al. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest. 2002;110(11):1729-1738.
36. Horvath G, Mendes ES, Schmid N, et al. The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. J Allergy Clin Immunol. 2007;120(5):1103-1109.
37. Huiart L, Ernst P, Ranouil X, Suissa S. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J. 2005;25(4):634-639.
38. Macie C, Wooldrage K, Manfreda J, Anthonisen NR. Inhaled corticosteroids and mortality in COPD. Chest. 2006;130(3):640-646.
39. Löfdahl CG, Postma DS, Pride NB, Boe J, Thorén A. Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Eur Respir J. 2007;29(6):1115-1119.
40. Man SFP, Sin DD. Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):78-82.